Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Analgesics and asthma.

Andrew Szczeklik1, Ewa Nizankowska, Lucyna Mastalerz

  • 1Department of Medicine, Jagellonian University School of Medicine, Cracow, Poland. mmszczek@cyf-kr.edu.pl

American Journal of Therapeutics
|April 10, 2002
PubMed
Summary

Aspirin-induced asthma (AIA) involves NSAID hypersensitivity and leukotriene overproduction. Patients with AIA should avoid COX-1 inhibitors but can often safely use COX-2 inhibitors like coxibs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Vitro Evaluation of Combination Therapy with Doxorubicin and Quercetin for Uveal Melanoma.

Current issues in molecular biology·2026
Same author

Expression of PD-L1 and PD-L2 and Their Association with IFN-γ/STAT1/STAT3 Signaling in Human Clear Cell Renal Cell Carcinoma (ccRCC).

Journal of clinical medicine·2026
Same author

Two Distinct Transcriptional Subtypes of Severe Type 2 Asthma in NSAID-Exacerbated Respiratory Disease.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Design, synthesis, and biological profiling of fluorinated cannabidiol and cannabigerol derivatives as promising therapeutic agents.

Journal of cannabis research·2026
Same author

Potential Regulatory Role of miR-15b, miR-99b, and miR-181a of the Shikonin-Induced MAPK/ERK Apoptotic Signaling Pathway in Renal Carcinoma.

Biomedicines·2025
Same author

Sarcoid-like reaction induced by aspirin treatment following aspirin desensitization in a patient with aspirin-exacerbated respiratory disease.

Polish archives of internal medicine·2025

Area of Science:

  • Pulmonology
  • Clinical Immunology
  • Pharmacology

Background:

  • Asthma incidence is rising globally, posing public health and economic challenges.
  • Aspirin-induced asthma (AIA) is a specific syndrome where cyclooxygenase (COX)-1 inhibiting NSAIDs worsen asthma.
  • AIA is preceded by eosinophilic rhinosinusitis, nasal polyposis, and aspirin hypersensitivity.

Purpose of the Study:

  • To describe the clinical presentation and biochemical characteristics of aspirin-induced asthma.
  • To highlight diagnostic challenges and management strategies for AIA.
  • To review the safety and tolerability of alternative analgesics in AIA patients.

Main Methods:

  • Diagnosis relies on characteristic symptoms and aspirin provocation tests, as no in vitro test exists.

Related Experiment Videos

  • Biochemical analysis reveals chronic overproduction of cysteinyl leukotrienes and overexpression of leukotriene C4 synthase.
  • Genetic polymorphism of leukotriene C4 synthase may contribute to AIA pathogenesis.

    • Main Results:

    • AIA often follows a severe, protracted course, frequently requiring systemic corticosteroids.
    • Patients must avoid aspirin and other COX-1 inhibitors to prevent severe reactions.
    • Paracetamol shows low cross-sensitivity, and COX-2 inhibitors (coxibs) are generally well-tolerated.

    Conclusions:

    • AIA is characterized by eosinophilic inflammation and leukotriene pathway dysregulation.
    • Strict avoidance of COX-1 inhibitors and careful consideration of alternative analgesics are crucial for AIA management.
    • Specific COX-2 inhibitors offer a safer alternative for pain management in patients with AIA.